May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

In May, the FDA granted significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.

Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.

In May, the FDA granted 5 significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.

Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday that the U.S. drugs regulator would look for ways ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Startup Clairity scored a greenlight from the FDA for the agency's first artificial intelligence tool designed to predict ...

Recent advances have resulted in highly effective "tissue-agnostic" drugs that treat cancers based on their molecular markers ...

The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and ...

A Danish research team has cracked the full biosynthesis of Taxol enabling cheaper and eco-friendly production in yeast.

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...